National Law Journal

'Nuclear Option'?: Eli Lilly Taps Big Law Firms in Federal Drug Pricing Dispute

The Health Resources and Services Administration has “invoked the nuclear option of removal from not only the 340B program but also Medicaid and Medicare Part B if manufacturers implement a cash replenishment model,” counsel for Eli Lilly—the manufacturer of Mounjaro, Trulicity and other treatments for weight loss or diabetes—alleged in their complaint.
3 minute read

National Law Journal

Baltimore City Govt., After Winning Opioid Jury Trial, Preparing to Demand an Additional $11B for Abatement Costs

Susman Godfrey partner Bill Carmody said the $266 million “verdict was an important step toward helping Baltimore recover so that it can continue to be one of the best cities in America and a place where all of its citizens can be healthy and succeed."
3 minute read

Law.com

Lawsuits Mount Over Moderna's RSV Vaccine

The newest case is the fifth to bring similar allegations against Moderna in the same court, with three others, all filed Nov. 5, surfaced by Law.com Radar.
2 minute read

New Jersey Law Journal

Drugmaker Wins $70.5M After Fed Judge Says Generic Sales Were Blocked

"The court finds Sandoz’s lost profits following the launch of generic treprostinil were a natural and probable consequence of United Therapeutics' breach of its promise," U.S. District Judge Brian Martinotti said.
4 minute read

National Law Journal

DC Judge, Applying 'Loper Bright,' Dismisses Complaint in Medicare Drug-Classification Dispute

U.S. District Senior Judge Beryl A. Howell ruled that federal law “precludes the exercise of jurisdiction to review the agency’s classification of certain oral-only drugs as ‘renal dialysis services’ and its decision to identify [Ardelyx Inc.’s drug Xphozah] as qualifying for such classification.”
4 minute read

New Jersey Law Journal

3rd Circuit Revives Class Action Against Bayer Over Benzene-Contaminated Products

“Since the contaminated products contained a defect that rendered them unusable, the products were worth less than their full purchase price,” Judge Cindy K. Chung said. “To hold otherwise would be to conclude that an unusable product is worth the same as a usable one—a conclusion that resists logic.”
4 minute read

The Legal Intelligencer

Life Sciences M&A Set to Boom, Litigation to Remain Steady Under New Trump Admin

“The campaign we have all just gone through has not been very focused on a lot of policy detail," said Buchanan Ingersoll & Rooney life sciences industry group co-leader Jason Parish. "There’s a lot of ambiguity.”
5 minute read

Litigation Daily

Litigation Leaders: Mark Jones of Nelson Mullins on Helping Clients Assemble ‘Dream Teams’

“We are often selected as members of virtual trial teams with other national firms not only for our substantive experience and talent but also because of our ability to work collaboratively with other firms, which is always in the clients’ interest.”
10 minute read

Delaware Business Court Insider

Wilson Sonsini Knocks Out Claims Against Inhibrx Biosciences in Trade Secrets Verdict

"The most important thing about the win is it lets scientists who are really dedicated to trying to improve the lives of cancer patients to get back to focusing on that," said Luis Li, a Wilson Sonsini attorney who served as lead trial counsel for Inhibrx.
3 minute read

Law.com

Pharmacies Accuse GoodRx of 'Inviting Price-Fixing' in Series of Antitrust Class Actions

"This case involves an unlawful price-fixing agreement among several PBMs—orchestrated by the PBM rate aggregator, GoodRx—to suppress the prices paid to independent pharmacies for generic drugs," according to one complaint filed Nov. 1 in the U.S. District Court for the Central District of California.
4 minute read

Resources

  • Yearly Roundup: Strategic Insights for Law Firm Decision Making

    Brought to you by CARET Legal

    Download Now

  • Lex Machina Contracts: Commercial Litigation Report 2024

    Brought to you by LexisNexis®

    Download Now

  • White Collar Investigation Practice: Global Expertise in Complex Investigations

    Brought to you by HaystackID

    Download Now

  • Criminal Division's Evaluation of Corporate Compliance Programs: September 2024 Updates Review

    Brought to you by NAVEX Global

    Download Now